Surgical Science Sweden AB (publ) (SUSRF)
USD 12.75
(0.0%)
USD 12.75
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 214.28 Million SEK | 23.57% |
| 2022 | 25.9 Million USD | 64.22% |
| 2021 | 12.66 Million USD | 221.05% |
| 2020 | 3.68 Million USD | 12.83% |
| 2019 | 3.31 Million USD | 1604.84% |
| 2018 | -220.28 Thousand SEK | 13.04% |
| 2017 | -274.8 Thousand SEK | -126.81% |
| 2016 | 945.04 Thousand SEK | -10.45% |
| 2015 | 1.05 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 4.29 Million USD | 28.7% |
| 2024 Q1 | 25.97 Million SEK | -80.41% |
| 2023 Q3 | 5.53 Million USD | 7.86% |
| 2023 Q4 | 6.71 Million USD | 21.38% |
| 2023 Q2 | 5.13 Million USD | -14.49% |
| 2023 Q1 | 6 Million USD | -16.73% |
| 2023 FY | - USD | 23.57% |
| 2022 Q1 | 3.93 Million SEK | -40.59% |
| 2022 Q4 | 7.2 Million USD | 35.28% |
| 2022 FY | - USD | 64.22% |
| 2022 Q2 | 4.42 Million SEK | 12.34% |
| 2022 Q3 | 5.32 Million USD | 20.43% |
| 2021 Q4 | 6.62 Million SEK | 64.77% |
| 2021 Q2 | 963.96 Thousand SEK | -31.16% |
| 2021 Q1 | 1.4 Million SEK | -88.92% |
| 2021 Q3 | 4.02 Million SEK | 317.27% |
| 2021 FY | - USD | 221.05% |
| 2020 Q1 | -807 Thousand SEK | -106.5% |
| 2020 FY | - USD | 12.83% |
| 2020 Q4 | 12.64 Million SEK | 73.17% |
| 2020 Q3 | 7.3 Million SEK | 772.28% |
| 2020 Q2 | 837 Thousand SEK | 203.72% |
| 2019 FY | - USD | 1604.84% |
| 2019 Q1 | -5.06 Million SEK | -191.17% |
| 2019 Q2 | -1.67 Million SEK | 66.93% |
| 2019 Q3 | 9.5 Million SEK | 666.89% |
| 2019 Q4 | 12.42 Million SEK | 30.72% |
| 2018 Q3 | -986 Thousand SEK | 44.23% |
| 2018 Q4 | 5.55 Million SEK | 663.79% |
| 2018 FY | - SEK | 13.04% |
| 2018 Q1 | -4.76 Million SEK | -188.03% |
| 2018 Q2 | -1.76 Million SEK | 62.89% |
| 2017 FY | - SEK | -126.81% |
| 2017 Q3 | -500 Thousand SEK | -400.0% |
| 2017 Q4 | 5.41 Million SEK | 1182.4% |
| 2017 Q2 | -100 Thousand SEK | -105.0% |
| 2017 Q1 | 2 Million SEK | -80.39% |
| 2016 FY | - SEK | -10.45% |
| 2016 Q1 | 800 Thousand SEK | 0.0% |
| 2016 Q4 | 10.2 Million SEK | 563.64% |
| 2016 Q3 | -2.2 Million SEK | -1000.0% |
| 2016 Q2 | -200 Thousand SEK | -125.0% |
| 2015 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 2673.809% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | -2.84 Million USD | 7628.471% |
| Cannabis Sativa, Inc. | -1.11 Million USD | 19326.618% |
| CompuMed, Inc. | 690.19 Thousand USD | -30947.493% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | -0.704% |
| Cogstate Limited | 9.89 Million USD | -2066.423% |
| CareView Communications, Inc. | -210.04 Thousand USD | 102121.51% |
| Craneware plc | 54.26 Million USD | -294.926% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 1843.227% |
| Certive Solutions Inc. | -704.66 Thousand USD | 30509.812% |
| Drug Free Solution, Inc. | -1.39 Million USD | 15461.879% |
| DATATRAK International, Inc. | 2.72 Million USD | -7753.5% |
| Strainsforpains, Inc. | -65.61 Thousand USD | 326707.225% |
| Healixa Inc. | -6.32 Million USD | 3490.428% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 10.16 Million USD | -2007.336% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | 50462.642% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | - USD | -Infinity% |
| iCoreConnect Inc. | -11.87 Million USD | 1903.855% |
| IQ-AI Limited | -370.35 Thousand USD | 57960.204% |
| Cannabiz Mobile, Inc. | -750.00 USD | 28571700.0% |
| Mednow Inc. | -28.12 Million USD | 861.951% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | 79253.6% |
| MediXall Group, Inc. | -6.52 Million USD | 3384.806% |
| Mitesco, Inc. | -11.96 Million USD | 1891.192% |
| MobileSmith, Inc. | -13.83 Million USD | 1648.6% |
| NantHealth, Inc. | -38.53 Million USD | 656.099% |
| Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 12719.965% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | -12.08 Million USD | 1872.927% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 1871.203% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | -16236.188% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | -286648.294% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | 1758857.387% |
| Renalytix Plc | -28.52 Million USD | 851.331% |
| Revium Recovery Inc. | -678 Thousand USD | 31705.752% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | -369.00 USD | 58072457.724% |
| Vaso Corporation | 4.19 Million USD | -5008.153% |
| Vynleads, Inc. | -235.72 Thousand USD | 91005.119% |